number of applications.2 Recently, we synthesized various
BODIPY-labeled pirenzepine derivatives to investigate their
binding to GFP-labeled muscarinic M1 receptors by fluorescence
resonance energy transfer (FRET).3 BODIPY dyes are com-
mercially available4 in small quantities suitable for biochemical
experiments, but amounts typically required for synthetic organic
chemistry are prohibitively expensive. Therefore, as part of our
program to develop fluorescent combinatorial libraries to
identify new ligands of orphan GPCRs by FRET,5 we were
interested in the synthesis of novel and readily accessible
BODIPY-like fluorescent dyes.
In this paper, we describe a rapid and flexible method for
the synthesis of novel 4,4-dialkoxy- or 4,4-diaryloxy-diaza-s-
indacenes 2 by reacting BODIPY 1 with Lewis acids. The
spectroscopic properties of the resulting compounds were similar
or even better than those of the parent BODIPY compound,
highlighting their interest as new fluorescent dyes. Even if recent
articles report on the synthesis of new BODIPY dyes,6 to our
knowledge only one structure of type 2 has been previously
described in the literature.7
Convenient Method To Access New 4,4-Dialkoxy-
and 4,4-Diaryloxy-diaza-s-indacene Dyes:
Synthesis and Spectroscopic Evaluation
Chouaib Tahtaoui,†,|, Ce´cile Thomas,†,| Franc¸ois Rohmer,†
Philippe Klotz,†,§ Guy Duportail,‡ Yves Me´ly,*,‡
Dominique Bonnet,*,† and Marcel Hibert†
De´partement de Pharmacochimie de la Communication
Cellulaire, and De´partement de Pharmacologie et
Physicochimie des Interactions Cellulaires et Mole´culaires,
Institut Gilbert Laustriat, UMR 7175-LC1 ULP/CNRS,
Faculte´ de Pharmacie de Strasbourg, 74 Route du Rhin,
67401 Illkirch, France
dominique.bonnet@pharma.u-strasbg.fr;
ReceiVed July 28, 2006
Synthesis. BODIPY dye 1 has previously been described in
the literature.2f,6e,8 Recently, Golovkova et al. have described a
A straightforward method for the synthesis of original 4,4-
dialkoxy- or 4,4-diaryloxy-diaza-s-indacenes (BODIPY)
derivatives obtained by treatment of BODIPY 1 with various
alcohols in the presence of AlCl3 is described. The novel
compounds are characterized by spectroscopic properties
similar to those of the parent BODIPY 1, absorption and
emission spectra with similar band shapes, high molar
absorption coefficients (ꢀλmax ≈ 80 000 M-1 cm-1), and for
most of them high fluorescence quantum yields (Φexp from
0.52 to 0.71). Among all of the new compounds synthesized,
the dye 2h exhibits higher fluorescence quantum yield (0.71)
and lifetime (4.09 ns) than compound 1 and a good chemical
stability toward conditions compatible with biological cell-
based assays.
(1) Karolin, J.; Johansson, L. B.-A.; Strandberg, L.; Ny, T. J. Am. Chem.
Soc. 1994, 116, 7801.
(2) (a) Wagner, R. W.; Lindsey, J. S. Pure Appl. Chem. 1996, 68, 1373.
(b) Metzker, M. L.; Lu, J.; Gibbs, R. A. Science 1996, 271, 1420. (c)
Malinin, V. S.; Haque, Md. E.; Lentz, B. R. Biochemistry 2001, 40, 8292.
(d) Luedtke, N. W.; Carmichael, P.; Tor, Y. J. Am. Chem. Soc. 2003, 125,
12374. (e) Baruah, M.; Qin, W.; Basaric´, N.; De Borggraeve, W. M.; Boens,
N. J. Org. Chem. 2005, 70, 4152. (f) Golovkova, T. A.; Kozlov, D. V.;
Neckers, D. C. J. Org. Chem. 2005, 70, 5545. (g) Qi, X.; Jun, E. J.; Xu, L.;
Kim, S.-J.; Hong, J. S. J.; Yoon, Y. J.; Yoon, J. J. Org. Chem. 2006, 71,
2881. (h) Ziessel, R.; Bonardi, L.; Retailleau, P.; Ulrich, G. J. Org. Chem.
2006, 71, 3093. (i) Rurak, K.; Resch-Genger, U. Chem. Soc. ReV. 2002,
31, 116.
(3) (a) Ilien, B.; Franchet, C.; Bernard, P.; Morisset, S.; Weill, C. O.;
Bourguignon, J.-J.; Hibert, M.; Galzi, J.-L. J. Neurochem. 2003, 85, 768.
(b) Tahtaoui, C.; Parrot, I.; Klotz, P.; Guillier, F.; Galzi, J.-L.; Hibert, M.;
Ilien, B. J. Med. Chem. 2004, 47, 4300. (c) Bonnet, D.; Ilien, B.; Galzi,
J.-L.; Riche´, S.; Antheaune, C.; Hibert, M. Bioconjugate Chem. 2006, 17,
1618.
(4) (a) Haugland, R. P. The Handbook. A Guide to Fluorescent Probes
and Labeling Technologies, 11th ed.; Invitrogen: Oregon, 2006. (b)
BODIPY is a registred trademark of Molecular Probes, Inc., Eugene, OR.
(5) Hibert, M.; Franchet, C.; Galzi, J. L.; Pattus, F.; Guillier, F. Patent
Application WO 2006003330 (12/01/2006).
(6) (a) Goze, C.; Ulrich, G.; Ziessel, R. Org. Lett. 2006, 8, 4445. (b)
Goze, C.; Ulrich, G.; Mallon, L. J.; Allen, B. D.; Harriman, A.; Ziessel, R.
J. Am. Chem. Soc. 2006, 128, 10231. (c) Ka´lai, T.; Hideg, K. Tetrahedron
2006, 62, 10352. (d) Ulrich, G.; Goze, C.; Guardigli, M.; Roda, A.; Ziessel,
R. Angew. Chem., Int. Ed. 2005, 44, 3694. (e) Chen, J.; Burghart, A.;
Derecskei-Kovacs, A.; Burgess, K. J. Org. Chem. 2000, 65, 2900.
(7) Kim, H.; Burghart, A.; Welch, M. B.; Reibenspies, J.; Burgess, K.
Chem. Commun. 1999, 18, 1889.
4,4-Difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY) dyes
are highly fluorescent molecules1 that have been used for a large
* To whom correspondence should be addressed. Phone: +33(0)390244236.
Fax: +33(0)390244310.
† De´partement de Pharmacochimie de la Communication Cellulaire.
‡ De´partement de Pharmacologie et Physicochimie des Interactions Cellulaires
et Mole´culaires.
§ In fond memory of Dr. Philippe Klotz, our dear friend, colleague, and mentor
who died untimely on June 9th, 2005, aged 40.
| These authors contributed equally to this work.
Present address: Arpida AG, Research & Development of Anti-Infectives,
Dammstrasse 36, CH-4142 Muenchenstein, Switzerland.
10.1021/jo061567m CCC: $37.00 © 2007 American Chemical Society
Published on Web 12/09/2006
J. Org. Chem. 2007, 72, 269-272
269